| Revenue growth | FY26 -8% YoY; Q4 ₹235cr (-31% YoY). |
|---|---|
| Margins | FY26 EBITDA 31%; Q4 Gross Margin 56%. |
| Demand visibility | Strong visibility in CM segment; confirmed orders in select PI programs. |
| Management confidence | High for FY27; destocking in PI segment completed. |
Growth
FY26 Revenue: ₹947cr (-8% YoY); EBITDA: 31% (vs 37% FY25); Contrast Media grew 23% full year.
Outlook
Planned ₹1,040cr capex (₹1,000cr Vizag, ₹40cr Hyderabad); guiding for double-digit growth in Contrast Media for FY27.
Risks
PI/API segment revenue fell 35% due to customer destocking; pricing pressure from imports in artificial sweeteners.
Earnings Call filed with NSE, NSE: BLUEJET. Summary written with AI assistance from the document.
Blue Jet Healthcare Ltd: key numbers
- Share price
- ₹545.50
- Market cap
- ₹9,463 Cr
- Revenue (annual)
- ₹947.3 Cr
- Net profit (annual)
- ₹247.8 Cr
- P/E (TTM)
- 40.3×Sector 47.4×
- Promoter holding
- 73.15%-6.66% QoQ
- FII holding
- 0.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Blue Jet Healthcare Ltd
All →Blue Jet Healthcare Annual General Meeting
Blue Jet Healthcare held its 58th AGM, approving audited financials, a Re 1.20 dividend, and director re-appointments. No material amendments were noted.
Blue Jet Healthcare Annual Report
Blue Jet Healthcare Limited has released its Annual Report for FY 2025-26. The 58th Annual General Meeting is scheduled for September 21, 2026, via video conferencing.
Blue Jet Healthcare Business Update
Blue Jet Healthcare Limited has released its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26. The report details the company's ESG performance and statutory disclosures.
Blue Jet Healthcare Annual General Meeting
Blue Jet Healthcare Limited will hold its 58th Annual General Meeting on September 21, 2026. The agenda includes a final dividend recommendation of ₹1.20 per share.
Blue Jet Healthcare Investor Presentation: Key Takeaways
Blue Jet Healthcare reported Q1 FY27 revenue of INR 293 crores (+25% QoQ) and EBITDA of INR 98 crores. Management highlighted a shift toward higher-value PI and API verticals alongside significant upcoming capex.
Blue Jet Healthcare Earnings Call Transcript: Key Takeaways
Blue Jet Healthcare reported Q1 FY27 revenue of ₹2,931mn, up 25% QoQ but down 17% YoY. Management is focusing on capacity expansion and forward integration into advanced contrast media intermediates.